283 reports of this reaction
2.2% of all LORATADINE AND PSEUDOEPHEDRINE SULFATE reports
#7 most reported adverse reaction
HEADACHE is the #7 most commonly reported adverse reaction for LORATADINE AND PSEUDOEPHEDRINE SULFATE, manufactured by Bayer HealthCare LLC.. There are 283 FDA adverse event reports linking LORATADINE AND PSEUDOEPHEDRINE SULFATE to HEADACHE. This represents approximately 2.2% of all 12,600 adverse event reports for this drug.
Patients taking LORATADINE AND PSEUDOEPHEDRINE SULFATE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for LORATADINE AND PSEUDOEPHEDRINE SULFATE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for LORATADINE AND PSEUDOEPHEDRINE SULFATE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 283 FDA reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.2% of all adverse event reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE, making it a notable side effect.
If you experience headache while taking LORATADINE AND PSEUDOEPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.